依达拉奉治疗急性脑出血临床疗效观察

Clinical efficacy of edaravone on the treatment of acute cerebral hemorrhage

目的观察依达拉奉对急性脑出血的治疗效果。方法将116例脑出血患者随机分为治疗组和对照组。治疗组在常规治疗的基础上,给予依达拉奉30mg加5%葡萄糖或生理盐水100ml静脉滴注,30分钟内滴完,每日2次,共19天。治疗组于治疗前及治疗后第19天分别进行神经功能缺损评分及疗效评定。结果治疗19天后,治疗组神经功能缺损评分为(9.6±6.3)分,明显低于对照组的(14.4±7.6)分(P<0.05);治疗组的显效率和有效率分别为48.3%和86.2%,显著高于对照组的20.1%和62.1%(P<0.05)。结论依达拉奉可促进脑出血患者的神经功能康复。

Objective To evaluate the efficacy of edaravone on the treatment of acute cerebral hemorrhage, Methods 116 cases were divided into treatment group and control group randomly. Neurological functional feficit scores and the efficacy was recorded. Results After 19days treatment, the neurological functional deficit scores of treated group were 9.6±6.3, whereas those of the control group were 14.4±7.6. There was significant difference between rate（treated group：48.3% ;control group： 20.1% ; P〈0.05）. Conclusion Edaravone can accelerate the recovery of neural function after cerebral hemorrhage.